Anu Life Sciences

Anu Life Sciences is a pharmaceutical company based in Hyderabad, India, that specializes in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced drug intermediates. The company has established a strong presence in the global market through its focus on high-demand therapeutic areas, particularly metabolic disorders such as Type 2 diabetes. Their product portfolio features a comprehensive range of "Gliptins" (DPP-4 inhibitors) and "Gliflozins" (SGLT2 inhibitors), which are critical components in modern diabetes management. Anu Life Sciences operates state-of-the-art manufacturing facilities that adhere to international quality standards and Good Manufacturing Practice (GMP) guidelines. In addition to its generic API offerings, the company provides Contract Research and Manufacturing Services (CRAMS) to support the drug development needs of international pharmaceutical and biotech partners.